Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Amortization - Deferred Charges Cost of Revenue EBIAT Gross Profit Long-Term Debt Issuances Long-Term Debt Repayments Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Outstanding Shares Outstanding Short-Term Debt repayments

Trinity Biotech (TRIB) Receivables - Other (2023 - 2025)

Trinity Biotech's Receivables - Other history spans 3 years, with the latest figure at $16000.0 for Q4 2025.

On a quarterly basis, Receivables - Other fell 90.48% to $16000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $16000.0, a 90.48% decrease, with the full-year FY2025 number at $16000.0, down 90.48% from a year prior.
Receivables - Other hit $16000.0 in Q4 2025 for Trinity Biotech, down from $168000.0 in the prior quarter.
Over the last five years, Receivables - Other for TRIB hit a ceiling of $168000.0 in Q4 2024 and a floor of $16000.0 in Q4 2025.
Historically, Receivables - Other has averaged $97000.0 across 3 years, with a median of $107000.0 in 2023.
Biggest five-year swings in Receivables - Other: soared 57.01% in 2024 and later crashed 90.48% in 2025.
Tracing TRIB's Receivables - Other over 3 years: stood at $107000.0 in 2023, then soared by 57.01% to $168000.0 in 2024, then crashed by 90.48% to $16000.0 in 2025.
Business Quant data shows Receivables - Other for TRIB at $16000.0 in Q4 2025, $168000.0 in Q4 2024, and $107000.0 in Q4 2023.